Pluronic block copolymers inhibit low density lipoprotein self-association

Lipids

Volumn 47, Issue 10, 2012, Pages 995-1000

  Melnichenko, Alexandra A ^a   Aksenov, Denis V ^b   Myasoedova, Veronika A ^a,b   Panasenko, Oleg M ^b   Yaroslavov, Alexander A ^c   Sobenin, Igor A ^b   Bobryshev, Yuri V ^b,d   Orekhov, Alexander N ^a,b  

^a INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

^b Institute of Chemical Problems of Ecology   (Russian Federation)

^c MOSCOW STATE UNIVERSITY   (Russian Federation)

^d ST VINCENT S HOSPITAL   (Australia)

Author keywords

Aggregation; Atherosclerosis; LDL; Low density lipoproteins; Pluronic block copolymers

Indexed keywords

COPOLYMER; ETHYLENE OXIDE; LOW DENSITY LIPOPROTEIN; PLURONIC BLOCK COPOLYMER; POLOXAMER; PROPYLENE OXIDE; UNCLASSIFIED DRUG;

ARTICLE; COMPARATIVE STUDY; CRITICAL MICELLE CONCENTRATION; DRUG DESIGN; HUMAN; HUMAN TISSUE; HYDROPHILICITY; HYDROPHOBICITY; LIPOPHILICITY; PROTEIN AGGREGATION; PROTEIN ASSEMBLY;

HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LIPOPROTEINS; MICELLES; POLOXAMER; POLYMERS;

EID: 84866737542     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-012-3699-5     Document Type: Article

References (32)

1. Anitschkow NN, Chatalov S (1913) Über experimentelle Cholesterinsteatose und ihre Bedeutung für die Entstehung einiger pathologischer Prozesse. Zentralbl Allg Pathol 24:1-9
2. Smith EB (1974) The relationship between plasma and tissue lipids in human atherosclerosis. Adv Lpid Res 12:1-49
3. Mahley RW, Innerarity TL, Weisgraber KH, Oh SY (1979) Altered metabolism (in vivo and in vitro) of plasma lipoproteins after selective modification of lysine residues of apoproteins. J Clin Invest 64:743-750
4. Alaupovic P (1971) Apolipoproteins and lipoproteins. Atherosclerosis 13:141-146
5. Bobryshev YV (2006) Monocyte recruitment and foam cell formation in atherosclerosis. Micron 37:208-222
6. Bates SR, Wissler RW (1976) Effect of hyperlipemic serum on cholesterol accumulation in monkey aortic medial cells. Biochim Biophys Acta 450:78-88
7. Ross R, Harker L (1976) Hyperlipidemia and atherosclerosis. Science 193:1094-1100
8. Goldstein JL, Ho YK, Basu SK, Brown MS (1979) Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 76:333-337
9. Fogelman AM, Shechter I, Seager J, Hokom M, Child JS, Edwards PA (1980) Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. Proc Natl Acad Sci USA 77:2214-2218
10. Khoo JC, Miller E, McLoughlin P, Steinberg B (1990) Prevention of low density lipoprotein aggregation by high density lipoprotein or apolipoprotein A-I. J Lipid Res 31:645-652
11. Lopes-Virella MF, Klein RL, Lyons TJ, Stevenson HC, Witztum JL (1988) Glycosylation of low-density lipoprotein enhances cholesteryl ester synthesis in human monocyte-derived macrophages. Diabetes 37:550-557
12. Tertov VV, Sobenin IA, Gabbasov ZA, Popov EG, Orekhov AN (1989) Lipoprotein aggregation as an essential condition of intracellular lipid caused by modified low density lipoproteins. Biochem Biophys Res Commun 16:489-494
13. Bancells C, Benítez S, Jauhiainen M, Ordóñez-Llanos J, Kovanen PT, Villegas S, Sánchez-Quesada JL, Oörni K (2009) High binding affinity of electronegative LDL to human aortic proteoglycans depends on its aggregation level. J Lipid Res 50:446-455
14. Talbot RM, del Rio JD, Weinberg PD (2003) Effect of fluid mechanical stresses and plasma constituents on aggregation of LDL. J Lipid Res 44:837-845
15. Brunelli R, Balogh G, Costa G, De Spirito M, Greco G, Mei G, Nicolai E, Vigh L, Ursini F, Parasassi T (2010) Estradiol binding prevents ApoB-100 misfolding in electronegative LDL(-). Biochemistry 49:7297-7302
16. Tertov VV, Kaplun VV, Sobenin IA, Orekhov AA (1998) Lowdensity lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification. Atherosclerosis 138:183-195
17. Tertov VV, Sobenin IA, Gabbasov ZA, Popov EG, Jaakkola O, Solakivi T, Nikkari T, Smirnov VN, Orekhov AN (1992) Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization. Lab Invest 67:665-675
18. Parasassi T, De Spirito M, Mei G, Brunelli R, Greco G, Lenzi L, Maulucci G, Nicolai E, Papi M, Arcovito G, Tosatto SC, Ursini F (2008) Low density lipoprotein misfolding and amyloidogenesis. FASEB J 22:2350-2356
19. Bancells C, Villegas S, Blanco FJ, Benítez S, Gállego I, Beloki L, Pérez-Cuellar M, Ordóñez-Llanos J, Sánchez-Quesada JL (2010) Aggregated electronegative low density lipoprotein in human plasma shows a high tendency toward phospholipolysis and particle fusion. J Biol Chem 285:32425-32435
20. Bancells C, Benítez S, Ordóñez-Llanos J, Öörni K, Kovanen PT, Milne RW, Sánchez-Quesada JL (2011) Immunochemical analysis of the electronegative LDL subfraction shows that abnormal N-terminal apolipoprotein B conformation is involved in increased binding to proteoglycans. J Biol Chem 286:1125-1133
21. Greco G, Balogh G, Brunelli R, Costa G, De Spirito M, Lenzi L, Mei G, Ursini F, Parasassi T (2009) Generation in human plasma of misfolded, aggregation-prone electronegative low density lipoprotein. Biophys J 97:628-635
22. Llorente-Cortés V, Badimon L (2005) LDL receptor-related protein and the vascular wall: implications for atherothrombosis. Arterioscler Thromb Vasc Biol 25:497-504
23. Llorente-Cortés V, Otero-Viñas M, Camino-López S, Costales P, Badimon L (2006) Cholesteryl esters of aggregated LDL are internalized by selective uptake in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 26:117-123
24. Oörni K, Pentikäinen MO, Ala-Korpela M, Kovanen PT (2000) Aggregation, fusion, and vesicle formation of modified low density lipoprotein particles: molecular mechanisms and effects on matrix interactions. J Lipid Res 41:1703-1714
25. Plihtari R, Kovanen PT, Öörni K (2011) Acidity increases the uptake of native LDL by human monocyte-derived macrophages. Atherosclerosis 217:401-406
26. Lähdesmäki K, Öörni K, Alanne-Kinnunen M, Jauhiainen M, Hurt-Camejo E, Kovanen PT (2012) Acidity and lipolysis by group V secreted phospholipase A(2) strongly increase the binding of apoB-100-containing lipoproteins to human aortic proteoglycans. Biochim Biophys Acta 1821:257-267
27. Vinogradov SV, Batrakova EV, Li S, Kabanov AV (2004) Mixed polymer micelles of amphiphilic and cationic copolymers for delivery of antisense oligonucleotides. J Drug Target 12:517-526
28. Batrakova EV, Li S, Alakhov VY, Miller DW, Kabanov AV (2003) Optimal structure requirements for pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells. Farmacol Exp Ther 304:845-854
29. Alakhova DY, Rapoport NY, Batrakova EV, Timoshin AA, Li S, Nicholls D, Alakhov VY, Kabanov AV (2010) Differential metabolic responses to pluronic in MDR and non-MDR cells: a novel pathway for chemosensitization of drug resistant cancers. J Controlled Release 142:89-100
30. Batrakova EV, Li S, Li Y, Alakhov VY, Kabanov AV (2004) Effect of pluronic P85 on ATPase activity of drug efflux transporters. Pharm Res 21:2226-2233
31. Batrakova EV, Li S, Li Y, Alakhov VY, Elmquist WF, Kabanov AV (2004) Distribution kinetics of a micelle-forming block copolymer Pluronic P85. J Controlled Release 100:389-397
32. Johnston TP, Baker JC, Hall D, Jamal AS, Emeson EE, Palmer WK (1999) Potential downregulation of HMG-CoA reductase following chronic administration of P-407 to C57BL/6 mice. J Cardiovasc Pharmacol 34:831-842